article thumbnail

Cost-Effective Genetic Testing Advances Early Detection of Prostate Cancer

Scienmag

The research centered on using PCR-Restriction Fragment Length Polymorphism (PCR-RFLP), a molecular genetic approach, to detect mutations associated with increased prostate cancer susceptibility. The RFLP method detects SNPs by introducing restriction enzyme recognition sites, which vary based on genetic variants.

article thumbnail

New Genetic Links to Lipids Found Across Populations

Scienmag

In a groundbreaking study that reshapes our understanding of the genetic determinants of serum lipid levels, a consortium of international researchers has unveiled novel genetic loci influenced by the complex interplay between genetic variants and psychosocial factors.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

New Genetic Connection Discovered Between Iron Deficiency and Crohn’s Disease

Scienmag

A groundbreaking study conducted by biomedical scientists at the University of California, Riverside School of Medicine has unveiled new insights into the genetic underpinnings of iron deficiency anemia in patients with inflammatory bowel disease (IBD).

article thumbnail

SSRgenotyper: A new tool to digitally genotype simple sequence repeats

Scienmag

SSRgenotyper: A simple sequence repeat genotyping application for whole-genome resequencing and reduced representational sequencing projects.

article thumbnail

To Share or Not to Share Failed Genetic Screening Results with Patients

Worldwide Clinical Trials

When using genetic screening to identify clinical trial volunteers, a sponsor’s obligations for further testing and disclosure of results to patients and families are unclear, especially when the results have no impact on medical management. Guidance in this area is much needed. Read the full article!

Genetics 130
article thumbnail

FDA grants approval for bluebird’s Zynteglo to treat beta-thalassemia

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has granted approval for bluebird bio ’s Zynteglo (betibeglogene autotemcel, beti-cel) for the treatment of the underlying genetic cause of beta?thalassemia 0 genotypes. thalassemia in adult and paediatric patients.

article thumbnail

Predicting multi-omics from genotypes with OmicsPred

Medical Xpress

Work by an international research team led by Yu Xu and Michael Inouye at the Department of Public Health and Primary Care, University of Cambridge, has resulted in a unique resource for predicting multi-omics data directly from genotypes. A Research Briefing on the study is published in the same journal issue.